Market Report, "Sandoz International GmbH: PharmaVitae Profile", published

Recently published research from Datamonitor, "Sandoz International GmbH: PharmaVitae Profile", is now available at Fast Market Research
 
Jan. 20, 2011 - PRLog -- This analysis examines the historical and forecast performance for Sandoz in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Sandoz's strategic outlook across the next 6 years
* Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source

Highlights

Strategic insight into the prospects for Sandoz over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
Your key questions answered

* Benchmark Sandoz's performance against key rivals in the prescription pharmaceutical sector.
* Assess how Sandoz will sustain its pioneering position in the biosimilars market via the launch of generic Lovenox (enoxaparin) in 2010.
* Analyse how challenging US and German market conditions will see Sandoz target 'rest of world' and emerging markets for growth.


For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/109396_sandoz_international_gm...


Report Table of Contents:

Executive Summary

Key findings

Prescription pharmaceutical sales and growth rate performance, 2003-15

Financial performance

Sandoz: PharmaVitae forecasts at a glance

Strategic insight

2003-09: M&A drives geographic expansion

2009-15: Roll out of biosimilar and 'difficult to make' generics in new markets

Sandoz as a key component of the Novartis Group

Authorized generics minimize loss of revenue to external generic competitors

Provides Novartis with a biologics arm

SWOT analysis

Strengths

Weaknesses

pportunities

Threats

ABOUT THIS PROFILE

PharmaVitae Explorer database

Chapter structure

Quarterly update

Company introduction

Company sales

Company financials

Key products

Data sourcing

Analyst consensus

QUARTERLY NEWS UPDATE

Latest quarterly sales

Latest prescription pharma product news

Q3 2010

Q2 2010

Q1 2010

Q4 2009

Q3 2009

Q2 2009

Q1 2009

Latest corporate news

Q2 2010

Q1 2010

Q4 2009

Q3 2009

Q2 2009

Q1 2009

COMPANY INTRODUCTION

Key findings

Background

Key corporate developments

M&A history

Current corporate structure

COMPANY SALES

Key findings

Prescription pharmaceutical sales and growth rate analysis, 2003-15

Product analysis

Product analysis, 2003-09

Product analysis, 2009-15

Therapy area analysis

Geographic analysis

Molecule type analysis

Externalization analysis

COMPANY FINANCIALS

Key findings

Note regarding full-year 2009 financial data

Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2002-08

perating costs and profit analysis

perating costs and profit analysis, 2002-08

perating cost ratio and profit margin analysis, 2002-08

KEY PRODUCTS

verview

Gen. Lovenox

Ebewe oncology portfolio

Gen. Taxotere

Gen. Advair

Zarzio

Gen. Losec

Gen. Toprol-XL

Gen. Lotrel

Gen. Duragesic

Gen. Zocor

APPENDIX

References

Abbreviations

Exchange rates


About Datamonitor

The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment.  View more research from Datamonitor at http://www.fastmr.com/catalog/publishers.aspx?pubid=1002

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
End
Source: » Follow
Email:***@fastmr.com Email Verified
Zip:01267
Tags:Sandoz, Gen, Prescription, Pharmaceutical, Generic, Pharmavitae, Perating, Pharma, Molecule, Therapy
Industry:Medical, Research, Biotech
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share